Ursodeoxycholic acid 150mg

Soft capsule

Primary biliary cirrhosis (PBC) and for the dissolution of small to medium sized radiolucent, cholesterol-rich gall-stones in patients with a functioning gall bladder.
Catolis has a particular place in the treatment of patients in whom surgery is contraindicated or who are anxious to avoid surgery.
Paediatric population
Hepatobiliar disorder associated with cystic fibrosis in children aged 6 years to less than 18 years.

Off label indication: Gallstone prevention after weight loss surgery

Dosage: The dosage should be calculated based on the patient's body weight. The calculated dosage should be rounded to the nearest number of tablets.
Dissolving of cholesterol stones:
Usual dosage: 8 to 10 mg/kg/day, corresponding to, for example, four to six 150 mg tablets, or two to three tablets of 300 mg, or two tablets of 450 mg. The daily dose can be administered two or three times after the meals: two tablets should always be taken after the evening meal.

Children with cystic fibrosis aged 6 years to 18 years:
Treatment of hepatobiliary diseases as a result of cystic fibrosis 20 mg/kg/day divided in two to three divided doses. If necessary, increase to 30 mg/kg/day. This corresponds with four to ten tablets of 150mg, two to five tablets of 300 mg, or with two to three tablets of 450 mg, to be taken in one or two portions during the day.